drugset / Trial / NCT05560373

The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study

NCT05560373

RandomizedParallel-groupOpen-labelTreatment

Summary

Under the premise of basic treatment, to explore the improvement effect of huperzine A injection on short-term and long-term neurocognitive dysfunction in patients with aneurysmal subarachnoid hemorrhage after interventional/surgical treatment.

Timeline

Start
2022-09-30
Primary completion
2024-09-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Huperzine A Traditional medicine (herbal / TCM) 0.2 mg Intramuscular

Indications

No indication recorded.